BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khalili K, White MK, Jacobson JM. Novel AIDS therapies based on gene editing. Cell Mol Life Sci 2017;74:2439-50. [PMID: 28210784 DOI: 10.1007/s00018-017-2479-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Abana CZ, Lamptey H, Bonney EY, Kyei GB. HIV cure strategies: which ones are appropriate for Africa? Cell Mol Life Sci 2022;79:400. [PMID: 35794316 DOI: 10.1007/s00018-022-04421-z] [Reference Citation Analysis]
2 Borrajo A, Svicher V, Salpini R, Pellegrino M, Aquaro S. Crucial Role of Central Nervous System as a Viral Anatomical Compartment for HIV-1 Infection. Microorganisms 2021;9:2537. [PMID: 34946138 DOI: 10.3390/microorganisms9122537] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Nabi B, Rehman S, Pottoo FH, Baboota S, Ali J. Dissecting the Therapeutic Relevance of Gene Therapy in NeuroAIDS: An Evolving Epidemic. Curr Gene Ther 2020;20:174-83. [PMID: 32538727 DOI: 10.2174/1566523220666200615151805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hirakawa MP, Krishnakumar R, Timlin JA, Carney JP, Butler KS. Gene editing and CRISPR in the clinic: current and future perspectives. Biosci Rep 2020;40:BSR20200127. [PMID: 32207531 DOI: 10.1042/BSR20200127] [Cited by in Crossref: 87] [Cited by in F6Publishing: 90] [Article Influence: 43.5] [Reference Citation Analysis]
5 Golkar Z. CRISPR: a journey of gene-editing based medicine. Genes Genomics 2020;42:1369-80. [PMID: 33094378 DOI: 10.1007/s13258-020-01002-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Alam MA, Datta PK. Epigenetic Regulation of Excitatory Amino Acid Transporter 2 in Neurological Disorders. Front Pharmacol 2019;10:1510. [PMID: 31920679 DOI: 10.3389/fphar.2019.01510] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
7 Liu Q, He D, Xie L. Prediction of off-target specificity and cell-specific fitness of CRISPR-Cas System using attention boosted deep learning and network-based gene feature. PLoS Comput Biol 2019;15:e1007480. [PMID: 31658261 DOI: 10.1371/journal.pcbi.1007480] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
8 Yang Q, Feng F, Li P, Pan E, Wu C, He Y, Zhang F, Zhao J, Li R, Feng L, Hu F, Li L, Zou H, Cai W, Lehner T, Sun C, Chen L. Arsenic Trioxide Impacts Viral Latency and Delays Viral Rebound after Termination of ART in Chronically SIV-Infected Macaques. Adv Sci (Weinh) 2019;6:1900319. [PMID: 31380187 DOI: 10.1002/advs.201900319] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
9 Xiao Q, Guo D, Chen S. Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy. Front Cell Infect Microbiol 2019;9:69. [PMID: 30968001 DOI: 10.3389/fcimb.2019.00069] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 17.8] [Reference Citation Analysis]
10 Allen AG, Chung CH, Atkins A, Dampier W, Khalili K, Nonnemacher MR, Wigdahl B. Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection. Front Microbiol 2018;9:2940. [PMID: 30619107 DOI: 10.3389/fmicb.2018.02940] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 7.6] [Reference Citation Analysis]
11 Peterson TA, MacLean AG. Current and Future Therapeutic Strategies for Lentiviral Eradication from Macrophage Reservoirs. J Neuroimmune Pharmacol 2019;14:68-93. [PMID: 30317409 DOI: 10.1007/s11481-018-9814-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
12 Deng Q, Chen Z, Shi L, Lin H. Developmental progress of CRISPR/Cas9 and its therapeutic applications for HIV-1 infection. Rev Med Virol 2018;28:e1998. [PMID: 30024073 DOI: 10.1002/rmv.1998] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
13 Lee HJ, Lee KY, Park YH, Choi HJ, Yao Y, Nair V, Han JY. Acquisition of resistance to avian leukosis virus subgroup B through mutations on tvb cysteine-rich domains in DF-1 chicken fibroblasts. Vet Res 2017;48:48. [PMID: 28903753 DOI: 10.1186/s13567-017-0454-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
14 Ojha CR, Lapierre J, Rodriguez M, Dever SM, Zadeh MA, DeMarino C, Pleet ML, Kashanchi F, El-Hage N. Interplay between Autophagy, Exosomes and HIV-1 Associated Neurological Disorders: New Insights for Diagnosis and Therapeutic Applications. Viruses 2017;9:E176. [PMID: 28684681 DOI: 10.3390/v9070176] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
15 White MK, Kaminski R, Young WB, Roehm PC, Khalili K. CRISPR Editing Technology in Biological and Biomedical Investigation. J Cell Biochem 2017;118:3586-94. [PMID: 28460414 DOI: 10.1002/jcb.26099] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]